methylphenidate has been researched along with Intellectual Disability in 73 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Optimal dosing of methylphenidate is practical and effective in some children with hyperkinetic disorder and intellectual disability." | 9.17 | Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. ( Baird, G; Bernard, S; Chadwick, O; Golaszewski, A; Jichi, F; Kelly, J; Kennedy, J; Liang, H; Riemer, K; Rodney, L; Sharma, K; Sharma, SP; Simonoff, E; Taylor, E; Walwyn, R; West, N; Whitwell, S; Wood, N, 2013) |
| "Methylphenidate is a first-line treatment for ADHD, however no previous meta-analysis has evaluated its overall efficacy for ADHD in children with comorbid intellectual disability (ID) or borderline intellectual functioning." | 6.61 | Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis. ( Carvalho, AF; Chen, TY; Chen, YW; Cheng, YS; Li, DJ; Lin, PY; Stubbs, B; Sun, CK; Tseng, PT; Wu, CK; Wu, MK, 2019) |
| "Optimal dosing of methylphenidate is practical and effective in some children with hyperkinetic disorder and intellectual disability." | 5.17 | Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. ( Baird, G; Bernard, S; Chadwick, O; Golaszewski, A; Jichi, F; Kelly, J; Kennedy, J; Liang, H; Riemer, K; Rodney, L; Sharma, K; Sharma, SP; Simonoff, E; Taylor, E; Walwyn, R; West, N; Whitwell, S; Wood, N, 2013) |
| "Antipsychotics, particularly risperidone, appear to be effective in reducing problem behaviors in children with intellectual disability." | 4.93 | Pharmacotherapy for mental health problems in people with intellectual disability. ( Findling, RL; Ji, NY, 2016) |
| "This randomized clinical trial of methylphenidate in children with intellectual disability (ID) by Simonoff et al." | 3.79 | Commentary: Filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians--a response to Simonoff et al. (2013). ( Eugene Arnold, L, 2013) |
| "The commentary by Arnold (2013) raises a number of interesting issues and speculations about the action of methylphenidate in children with intellectual disability (ID) and associated neurodevelopmental disorders, such as autism spectrum disorders." | 3.79 | Commentary: RCT of optimal dose methylphenidate in children and adolescents with severe ADHD and ID--a reply to Arnold (2013). ( Baird, G; Bernard, S; Simonoff, E; Taylor, E, 2013) |
| " Analysis of dose-response curves revealed significant linear components of trend on measures tapping sustained attention, visual selective attention, auditory selective attention, as well as two tasks tapping inhibition/impulsivity: delay of gratification and match-to-sample." | 2.71 | Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. ( Casat, CD; Cleveland, LA; Faria, LP; Jerger, SW; Lachar, D; Lane, DM; Loveland, KA; Payne, CD; Pearson, DA; Roache, JD; Santos, CW, 2004) |
| "The aim of this study was to investigate the effects of ongoing methylphenidate (MPH) on ADHD-related and autistic symptoms in Pervasive Developmental Disorders (PDD) in children who did not present any adverse effects to an initial acute dose administered at the clinic." | 2.71 | Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study. ( Cianchetti, C; Di Martino, A; Melis, G; Zuddas, A, 2004) |
| "Parents of children with mental retardation or borderline IQ who took part in two drug studies were surveyed by mail 4 weeks after their involvement." | 2.68 | Consumer satisfaction with involvement in drug research: a social validity study. ( Aman, MG; Wolford, PL, 1995) |
| "Fenfluramine dosage was gradually increased to a standardized dose of 1." | 2.67 | Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects. ( Aman, MG; Arnold, LE; Kern, RA; McGhee, DE, 1993) |
| "The adverse side effects of methylphenidate were evaluated in 27 children with attention deficit hyperactivity disorder and IQs of 48 to 74 who participated in a double-blind study of two doses of methylphenidate and placebo." | 2.67 | Adverse side effects of methylphenidate among mentally retarded children with ADHD. ( Breaux, AM; Feldman, H; Gosling, A; Handen, BL; McAuliffe, S, 1991) |
| " Both groups were assessed for dyskinetic symptoms at ten weekly intervals as dosage was phased out in the neuroleptic group." | 2.66 | Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment. ( Aman, MG; Singh, NN, 1985) |
| "Methylphenidate is a first-line treatment for ADHD, however no previous meta-analysis has evaluated its overall efficacy for ADHD in children with comorbid intellectual disability (ID) or borderline intellectual functioning." | 2.61 | Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis. ( Carvalho, AF; Chen, TY; Chen, YW; Cheng, YS; Li, DJ; Lin, PY; Stubbs, B; Sun, CK; Tseng, PT; Wu, CK; Wu, MK, 2019) |
| "Probably pseudohypoaldosteronism was a coincidental finding in this girl with a CDK13 mutation, but because only limited information is known about CDK13-related disorders, further investigation could be more informative to clarify this presentation." | 2.61 | One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature. ( Ayman, A; Kremer, AK; van den Akker, M; Yakubov, R, 2019) |
| "Children and adolescents with autism spectrum disorders and intellectual disability have a high prevalence of attention-deficit/hyperactive disorder, mood disorders, catatonia and repetitive behaviours compared with children without autism." | 2.44 | Children with autism spectrum disorders and intellectual disability. ( McCarthy, J, 2007) |
| "Methylphenidate (2." | 1.91 | Complex Attention-Deficit/Hyperactivity Disorder in a Bilingual Child with Down Syndrome and Intellectual Disability. ( Carroll, G; Fogler, J; Froehlich, T; Moore, T; Nyp, SS; Soccorso, C, 2023) |
| "Although the relationship between attention-deficit/hyperactivity disorder (ADHD) and transport accidents has been shown, there is limited information on the relationship between medication and dose-response effects and transport accident risk." | 1.62 | Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH. ( Chen, VC; Chen, YL; Gossop, M; Liu, YC; Yang, YH, 2021) |
| "Methylphenidate was administered, for one week each, in a low dose of 0." | 1.26 | Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior. ( Aman, MG; Singh, NN, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (41.10) | 18.7374 |
| 1990's | 15 (20.55) | 18.2507 |
| 2000's | 13 (17.81) | 29.6817 |
| 2010's | 11 (15.07) | 24.3611 |
| 2020's | 4 (5.48) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, T | 1 |
| Soccorso, C | 1 |
| Fogler, J | 1 |
| Carroll, G | 1 |
| Froehlich, T | 1 |
| Nyp, SS | 1 |
| Sun, CK | 1 |
| Tseng, PT | 1 |
| Wu, CK | 1 |
| Li, DJ | 1 |
| Chen, TY | 1 |
| Stubbs, B | 1 |
| Carvalho, AF | 1 |
| Chen, YW | 1 |
| Lin, PY | 1 |
| Cheng, YS | 1 |
| Wu, MK | 1 |
| Yakubov, R | 1 |
| Ayman, A | 1 |
| Kremer, AK | 1 |
| van den Akker, M | 1 |
| Miller, J | 1 |
| Perera, B | 1 |
| Shankar, R | 1 |
| Joshi, G | 1 |
| Wilens, T | 1 |
| Firmin, ES | 1 |
| Hoskova, B | 1 |
| Biederman, J | 1 |
| Liu, YC | 1 |
| Chen, VC | 1 |
| Yang, YH | 1 |
| Chen, YL | 1 |
| Gossop, M | 1 |
| Operto, FF | 1 |
| Mazza, R | 1 |
| Campanozzi, S | 1 |
| Pastorino, GM | 1 |
| Amadori, E | 1 |
| Coppola, G | 1 |
| Tarrant, N | 1 |
| Roy, M | 1 |
| Deb, S | 1 |
| Odedra, S | 1 |
| Retzer, A | 1 |
| Roy, A | 1 |
| Eugene Arnold, L | 1 |
| Simonoff, E | 2 |
| Taylor, E | 2 |
| Baird, G | 2 |
| Bernard, S | 2 |
| Lipkin, PH | 1 |
| Ji, NY | 1 |
| Findling, RL | 2 |
| Deutsch, CK | 1 |
| Dube, WV | 1 |
| McIlvane, WJ | 1 |
| Mace, FC | 2 |
| Prager, KL | 1 |
| Thomas, K | 1 |
| Kochy, J | 1 |
| Dyer, TJ | 1 |
| Perry, L | 1 |
| Pritchard, D | 1 |
| Rowles, BM | 1 |
| Peyre, H | 1 |
| Delorme, R | 1 |
| Chadwick, O | 1 |
| Liang, H | 1 |
| Whitwell, S | 1 |
| Riemer, K | 1 |
| Sharma, K | 1 |
| Sharma, SP | 1 |
| Wood, N | 1 |
| Kelly, J | 1 |
| Golaszewski, A | 1 |
| Kennedy, J | 1 |
| Rodney, L | 1 |
| West, N | 1 |
| Walwyn, R | 1 |
| Jichi, F | 1 |
| Pearson, DA | 3 |
| Santos, CW | 3 |
| Roache, JD | 3 |
| Casat, CD | 3 |
| Loveland, KA | 3 |
| Lachar, D | 3 |
| Lane, DM | 3 |
| Faria, LP | 3 |
| Cleveland, LA | 3 |
| Aman, MG | 10 |
| Buican, B | 1 |
| Arnold, LE | 3 |
| CARTER, CH | 2 |
| MALEY, MC | 1 |
| LEVY, JM | 1 |
| JONES, BE | 1 |
| CROLEY, HT | 1 |
| BEAUJARD, M | 1 |
| REVOL, E | 1 |
| BUENO, UP | 1 |
| CAPP, AB | 1 |
| Jerger, SW | 2 |
| Payne, CD | 2 |
| Mansour, R | 1 |
| Henderson, JA | 1 |
| Di Martino, A | 1 |
| Melis, G | 1 |
| Cianchetti, C | 1 |
| Zuddas, A | 1 |
| Jou, R | 1 |
| Handen, B | 1 |
| Hardan, A | 1 |
| Dicesare, A | 1 |
| McAdam, DB | 1 |
| Toner, A | 1 |
| Varrell, J | 1 |
| Correia Filho, AG | 1 |
| Bodanese, R | 1 |
| Silva, TL | 1 |
| Alvares, JP | 1 |
| Aman, M | 2 |
| Rohde, LA | 1 |
| Bilgiç, A | 1 |
| Gürkan, K | 1 |
| Türkoğlu, S | 1 |
| McCarthy, J | 1 |
| Poling, A | 1 |
| Breuning, SE | 1 |
| Varley, CK | 1 |
| Trupin, EW | 1 |
| Singh, NN | 3 |
| Wolford, PL | 1 |
| Johnson, CR | 1 |
| Handen, BL | 6 |
| Lubetsky, MJ | 1 |
| Sacco, KA | 1 |
| Janosky, J | 3 |
| McAuliffe, S | 4 |
| Breaux, AM | 4 |
| Feldman, H | 4 |
| Kern, RA | 3 |
| McGhee, DE | 2 |
| Blum, NJ | 1 |
| Mauk, JE | 1 |
| McComas, JJ | 1 |
| Osborne, P | 1 |
| Tumuluru, R | 1 |
| Rojahn, J | 1 |
| del Medico, V | 1 |
| Detterman, DK | 1 |
| Thompson, LA | 1 |
| Searcy, E | 1 |
| Corbett, JA | 1 |
| Authier, J | 1 |
| Donaldson, J | 1 |
| Prica, G | 1 |
| Alperin, E | 1 |
| Ensz, G | 1 |
| Morrison, TL | 1 |
| Thomas, MD | 1 |
| Renshaw, DC | 1 |
| Schain, RJ | 1 |
| Springer, NS | 1 |
| Fricke, NL | 1 |
| Gosling, A | 3 |
| Voigt, RG | 1 |
| Johnson, GH | 1 |
| Brown, FR | 1 |
| Marks, RE | 2 |
| Turbott, SH | 2 |
| Wilsher, CP | 2 |
| Merry, SN | 2 |
| Ploof, DL | 1 |
| Payton, JB | 1 |
| Burkhart, JE | 1 |
| Hersen, M | 1 |
| Helsel, WJ | 1 |
| Knoll, E | 1 |
| Millichamp, CJ | 1 |
| McDaniel, KD | 1 |
| St Jean, A | 1 |
| Sterlin, C | 1 |
| Noe, W | 1 |
| Ban, TA | 1 |
| Omenn, GS | 2 |
| Alabiso, F | 1 |
| Blacklidge, VY | 1 |
| Ekblad, RL | 1 |
| Browder, JA | 1 |
| Davis, KV | 2 |
| Millichap, JG | 1 |
| Aymat, F | 1 |
| Sturgis, LH | 1 |
| Larsen, KW | 1 |
| Egan, RA | 1 |
| Sprague, RL | 1 |
| Werry, JS | 1 |
18 reviews available for methylphenidate and Intellectual Disability
| Article | Year |
|---|---|
Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Int | 2019 |
One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.
Topics: CDC2 Protein Kinase; Chelating Agents; DNA Mutational Analysis; Female; Humans; Infant; Intellectual | 2019 |
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 2020 |
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; | 2021 |
The effectiveness of methylphenidate in the management of Attention Deficit Hyperactivity Disorder (ADHD) in people with intellectual disabilities: A systematic review.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Int | 2018 |
Pharmacotherapy for mental health problems in people with intellectual disability.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Ce | 2016 |
Attention deficits, Attention-Deficit Hyperactivity Disorder, and intellectual disabilities.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Chro | 2008 |
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorde | 2010 |
Children with autism spectrum disorders and intellectual disability.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2007 |
Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.
Topics: Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; | 1982 |
What is so special about special education?
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Combined Modalit | 1997 |
Helping the patient who has pervasive developmental disorder.
Topics: Child; Child Development Disorders, Pervasive; Communication; Diagnosis, Differential; Haloperidol; | 2001 |
Behavioural and drug treatment of children with severe mental handicap.
Topics: Amphetamines; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bar | 1975 |
Minimal brain Dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Cerebral Palsy; Child; Child, Prescho | 1975 |
Nutrition and drug therapy for persons with developmental disabilities.
Topics: Anticonvulsants; Antidepressive Agents; Appetite; Dextroamphetamine; Drug-Related Side Effects and A | 1975 |
Pharmacological treatment of self-injurious behavior in mentally retarded persons.
Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Double-Blind | 1985 |
Genetic approaches to the syndrome of minimal brain dysfunction.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diseases in Tw | 1973 |
Genetic issues in the syndrome of minimal brain dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Dextroamphetamine; Diseases in Twins; Female; Humans; | 1973 |
28 trials available for methylphenidate and Intellectual Disability
| Article | Year |
|---|---|
Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2013 |
Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over | 2003 |
Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Central Nervous Syst | 2003 |
Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
Topics: Analysis of Variance; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous Syst | 2004 |
Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior; Central Nervous System Stimulants; Child; C | 2004 |
Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Central Nervous System | 2004 |
The effects of methylphenidate on a functional analysis of disruptive behavior: a replication and extension.
Topics: Adolescent; Attention Deficit and Disruptive Behavior Disorders; Behavior; Behavior Therapy; Central | 2005 |
Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous Sys | 2005 |
Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Child, Preschool; | 1982 |
Consumer satisfaction with involvement in drug research: a social validity study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clinical Trials | 1995 |
Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Preschool | 1994 |
Prediction of response to methylphenidate among children with ADHD and mental retardation.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Double-Blind | 1994 |
Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Cogni | 1993 |
Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation.
Topics: Aggression; Attention; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child | 1996 |
Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.
Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Central Nervous Sys | 1997 |
Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 1997 |
Effects and noneffects of methylphenidate in children with mental retardation and ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Double-Blind | 1992 |
Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Doubl | 1991 |
Adverse side effects of methylphenidate among mentally retarded children with ADHD.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Double-Blind Method; | 1991 |
Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorder | 1991 |
Fenfluramine and mental retardation.
Topics: Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Encopresis; Enuresis; Fenflurami | 1991 |
Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
Topics: Analysis of Variance; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child Behavio | 1990 |
Treatment of ADDH in mentally retarded children: a preliminary study.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Clinical Trials as Topic; Co | 1989 |
Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, | 1985 |
Clinical studies with propericiazine (R.P. 8909).
Topics: Acute Disease; Adolescent; Adult; Aged; Association; Behavior; Chlorpromazine; Chronic Disease; Clin | 1967 |
The effectiveness of methylphenidate hydrochloride (ritalin) on learning and behavior in public school educable mentally retarded children.
Topics: Adolescent; Child; Child Behavior; Clinical Trials as Topic; Education of Intellectually Disabled; E | 1971 |
Hyperkinetic behavior and learning disorders. 3. Battery of neuropsychological tests in controlled trial of methylphenidate.
Topics: Adolescent; Child; Child Behavior Disorders; Child, Preschool; Female; Humans; Hydrochloric Acid; In | 1968 |
Stereotyped behavior and activity level in severe retardates: the effect of drugs.
Topics: Adolescent; Analysis of Variance; Arousal; Humans; Intellectual Disability; Male; Methylphenidate; M | 1969 |
27 other studies available for methylphenidate and Intellectual Disability
| Article | Year |
|---|---|
Complex Attention-Deficit/Hyperactivity Disorder in a Bilingual Child with Down Syndrome and Intellectual Disability.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cesarean Section; Child; Down Syndrome; Female | 2023 |
Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
Topics: Accidents, Traffic; Adolescent; Attention Deficit and Disruptive Behavior Disorders; Attention Defic | 2021 |
Attention deficit hyperactivity disorder in genetically-determined intellectual disability.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Follow-Up S | 2019 |
Commentary: Filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians--a response to Simonoff et al. (2013).
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; In | 2013 |
Commentary: RCT of optimal dose methylphenidate in children and adolescents with severe ADHD and ID--a reply to Arnold (2013).
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; In | 2013 |
Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; In | 2013 |
Effects of stimulant medication under varied motivational operations.
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Choice Behavior; Delayed-Action Preparatio | 2009 |
A case of severe hyperthermia after administration of methylphenidate.
Topics: Central Nervous System Stimulants; Child; Fever; Humans; Intellectual Disability; Male; Methylphenid | 2012 |
The effects of reserpine and methylphenidylacetate (ritalin) in mental defectives, spastics, and epileptics.
Topics: Antihypertensive Agents; Diet, Reducing; Epilepsy; Intellectual Disability; Methylphenidate; Muscle | 1956 |
Parenteral use of methylphenidate (ritalin).
Topics: Brain; Brain Injuries; Diet, Reducing; Epilepsy; Humans; Intellectual Disability; Methylphenidate | 1957 |
Effects of methylphenidate (ritalin) on drug-induced drowsiness in mentally retarded patients.
Topics: Humans; Intellectual Disability; Methylphenidate; Persons with Mental Disabilities; Sleep; Sleep Sta | 1957 |
[Clinical tests of the activity of RP 8228 (phacetoperane) in an oligophrenic child].
Topics: Child; Diet, Reducing; Humans; Intellectual Disability; Methylphenidate; Piperidines | 1960 |
[Clinical results following the use of a new psychotonic in mentally defective children and mentally defective epileptics].
Topics: Child; Epilepsy; Humans; Intellectual Disability; Methylphenidate | 1962 |
Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants | 2004 |
Excessive masturbation and hypersexual behavior associated with methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dopamine Up | 2007 |
Effects of methylphenidate on the fixed-ratio performance of mentally retarded children.
Topics: Adolescent; Child; Conditioning, Operant; Female; Humans; Intellectual Disability; Male; Methylpheni | 1983 |
Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.
Topics: Adolescent; Adult; Attention; Behavior; Double-Blind Method; Eating; Female; Humans; Intellectual Di | 1982 |
Family practice grand rounds. Hyperactivity: a symptom, not a disease entity.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Epilepsy, Absence; | 1977 |
Judgments of educators and child-care personnel about appropriate treatment for mentally retarded or normal, overactive or withdrawn, boys.
Topics: Allied Health Personnel; Attitude of Health Personnel; Behavior Therapy; Child; Child Behavior Disor | 1976 |
Mentally retarded, hyperkinetic and psychotic.
Topics: Adult; Female; Humans; Hyperkinesis; Indoles; Intellectual Disability; Methylphenidate; Molindone; P | 1977 |
Mental retardation and ADHD!
Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Intellectual Disability; Methylphenida | 1992 |
Attention disorder in children: is the literature purged? Was it ever tainted?
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Crime; Fraud; Humans; Intellectual Disa | 1989 |
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2).
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Child; Chlorpromazine; Haloper | 1986 |
The use of methylphenidate in autism.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Humans; Intellectual Disabi | 1988 |
Inhibitory functions of attention in reducing hyperactive behavior.
Topics: Attention; Behavior Therapy; Brain; Child; Child, Preschool; Conditioning, Operant; Education of Int | 1972 |
Appropriate use of psychic drugs in school children.
Topics: Adolescent; Antidepressive Agents; Child; Child Behavior Disorders; Humans; Intellectual Disability; | 1972 |
The effect of drugs on stereotyped and nonstereotyped operant behaviors in retardates.
Topics: Adolescent; Adult; Behavior; Conditioning, Operant; Hospitalization; Humans; Intellectual Disability | 1971 |